| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.6 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |